» Articles » PMID: 10839801

Protective Immunity to Bordetella Pertussis Requires Both B Cells and CD4(+) T Cells for Key Functions Other Than Specific Antibody Production

Overview
Journal J Exp Med
Date 2000 Jun 6
PMID 10839801
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the fundamental nature of protective immunity to Bordetella pertussis, we studied intranasal immunization of adult mice with formalin-fixed B. pertussis (FFBP), followed by aerosol B. pertussis challenge. Mice given two doses of FFBP intranasally completely cleared a subsequent pertussis aerosol challenge from tracheae and lungs (defined as protection), but there was no correlation between levels of specific antibody and clearance of bacteria. Further, transfer of immune serum before aerosol challenge had minimal effects on bacterial burdens. However, pertussis-specific T cells producing interferon gamma but not interleukin 4 or interleukin 10 were detected in draining lymph nodes of FFBP-immunized mice. Significantly, repeated immunization of B cell knockout (BKO) mice resulted in partial protection, and complete protection was reconstituted by transfer of pertussis-immune B cells; reconstituted BKO mice had little if any detectable antipertussis antibodies. Immunization of mice lacking all T cells or lacking CD4(+) T cells did not lead to protection; in contrast, CD8(-) mice were protected. Mice depleted of CD4(+) T cells after immunization but before aerosol challenge, which thus had normal amounts of specific antibodies, were not optimally protected. Taken together, these data indicate that protective immunity to pertussis is dependent on both CD4(+) T cells and B cells, and both cell types provide significant functions other than specific antibody production.

Citing Articles

Genome-based prediction of cross-protective, HLA-DR-presented epitopes as putative vaccine antigens for multiple species.

Natrajan M, Hall J, Weigand M, Peng Y, Williams M, Momin M Microbiol Spectr. 2023; 12(1):e0352723.

PMID: 38054724 PMC: 10783135. DOI: 10.1128/spectrum.03527-23.


The whole-cell pertussis vaccine imposes a broad effector B cell response in mouse heterologous prime-boost settings.

Valeri V, Sochon A, Cousu C, Chappert P, Lecoeuche D, Blanc P JCI Insight. 2022; 7(21).

PMID: 36136586 PMC: 9675447. DOI: 10.1172/jci.insight.157034.


Reduced -specific CD4 T-Cell Responses at Older Age.

Lambert E, van Twillert I, Beckers L, Poelen M, Han W, Pieren D Front Aging. 2022; 2:737870.

PMID: 35822011 PMC: 9261443. DOI: 10.3389/fragi.2021.737870.


Contribution of a Novel Pertussis Toxin-Like Factor in Mediating Persistent Otitis Media.

Ma L, Sedney C, Su Y, Dewan K, Linz B, Harvill E Front Cell Infect Microbiol. 2022; 12:795230.

PMID: 35360099 PMC: 8963424. DOI: 10.3389/fcimb.2022.795230.


Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice.

Weaver K, Blackwood C, Horspool A, Pyles G, Sen-Kilic E, Grayson E Front Immunol. 2022; 13:838504.

PMID: 35211125 PMC: 8861382. DOI: 10.3389/fimmu.2022.838504.


References
1.
Ryan M, Murphy G, Gothefors L, Nilsson L, Storsaeter J, Mills K . Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J Infect Dis. 1997; 175(5):1246-50. DOI: 10.1086/593682. View

2.
Cherry J . Historical review of pertussis and the classical vaccine. J Infect Dis. 1996; 174 Suppl 3:S259-63. DOI: 10.1093/infdis/174.supplement_3.s259. View

3.
Berstad A, Holst J, Mogster B, Haugen I, Haneberg B . A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin. Vaccine. 1997; 15(12-13):1473-8. DOI: 10.1016/s0264-410x(97)00064-9. View

4.
Mahon B, Sheahan B, Griffin F, Murphy G, Mills K . Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes. J Exp Med. 1998; 186(11):1843-51. PMC: 2199147. DOI: 10.1084/jem.186.11.1843. View

5.
Barbic J, Leef M, Burns D, Shahin R . Role of gamma interferon in natural clearance of Bordetella pertussis infection. Infect Immun. 1997; 65(12):4904-8. PMC: 175707. DOI: 10.1128/iai.65.12.4904-4908.1997. View